Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
NCT02185911 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 308
Last updated 2016-03-08
Summary
To describe anaemia correction via haemoglobin measurements taken throughout observation period in ESA naive patients with chronic kidney disease initiated on darbepoetin alfa QM
Conditions
- Anaemia
- Chronic Kidney Disease (CKD)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2015-04-30
- Completion
- 2015-04-30
Countries
- Austria
- Bulgaria
- Czechia
- Greece
- Hungary
- Italy
- Poland
- Spain
Study Locations
More Related Trials
-
Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis
NCT00112008 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease
NCT00121602 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2 Study of Darbepoetin Alfa Extended Dosing
NCT00527215 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia
NCT02952092 ·Status: COMPLETED ·Phase: PHASE3
-
Darbepoetin Alfa Once Monthly Dosing Schedule Maintains Hemoglobin Concentration Comparable to Every 2 Weeks Dosing Schedule in Advanced Chronic Kidney Disease Patients Not on Dialysis: A Multicenter, Phase 4 Study
NCT07025460 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
NCT01652872 ·Status: COMPLETED ·Phase: PHASE3
-
Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents
NCT02136563 ·Status: COMPLETED
-
A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients
NCT00261521 ·Status: COMPLETED ·Phase: PHASE3
-
Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure
NCT00213291 ·Status: COMPLETED ·Phase: PHASE3
-
Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa
NCT02021318 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
NCT01888445 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia
NCT00563446 ·Status: COMPLETED ·Phase: NA
-
Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients
NCT05699109 ·Status: COMPLETED
-
A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
NCT02969655 ·Status: COMPLETED ·Phase: PHASE3
-
Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis
NCT00436995 ·Status: COMPLETED ·Phase: PHASE3
-
European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin Alfa
NCT00838097 ·Status: COMPLETED
-
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
NCT00436748 ·Status: TERMINATED ·Phase: PHASE3
-
Renal Anemia Refractory to Erythropoietin
NCT03480178 ·Status: UNKNOWN
-
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)
NCT02892149 ·Status: COMPLETED ·Phase: PHASE3
-
Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934
NCT02021409 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
NCT02253654 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Chronic Kidney Disease Not On Dialysis
NCT01318512 ·Status: COMPLETED
-
A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.
NCT00495365 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia
NCT02569515 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.
NCT04027517 ·Status: COMPLETED ·Phase: PHASE3